CDT EQUITY INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
CDT EQUITY INC. (CDT) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $2.40 million for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2026-09-08
- CDT EQUITY INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2026-06-30 was $500.00K.
- CDT EQUITY INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2026-03-31 was $1.90M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month |
|---|---|---|
| 2026-06-30 | $500.00K derived: S-1 6 month − 10-Q 3 month · filed 2026-09-08 | $2.40M S-1 · filed 2026-09-08 |
| 2026-03-31 | $1.90M 10-Q · filed 2026-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |